Clinical Trial Update: Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating aprepitant for prophylaxis of postoperative nausea and vomiting in outpatient plastic surgery; results completed and posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

Sponsor: University of Pittsburgh | Conditions: Postoperative Nausea and Vomiting | Phase 4 | Status: COMPLETED | Results posted: 2011-12-07